Pharmaceutically acceptable composition containing ambroxol in non-salt form

A technology of ambroxol hydrochloride and its composition, which is applied in the field of compositions composed of oral substances or drug-containing containers, can solve the problems that the therapeutic effect of the drug cannot reach the expected value and reduce the compliance of the product

Inactive Publication Date: 2011-07-20
沈阳华泰药物研究有限公司
View PDF3 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no better solution to the clinical application of this contradiction, which greatly reduces the compliance of the product, that is, some patients cannot take the medicine regularly as prescribed because of their unwillingness to take the medicine, so the therapeutic effect of the medicine cannot reach the expected value
[0005] The reason for the above phenomenon is that after ambroxol dissolves in water, it produces a relatively strong bitter and astringent taste, and in order to increase the solubility and make it in a solution state, the cosolvent ethanol and other auxiliary materials added cause a numb and spicy taste.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] The preparation of embodiment 1 ambroxol capsules and ambroxol hydrochloride capsules

[0016] Get Ambroxol 2.75g, and fill it in 100 No. 4 capsule shells on average, and each capsule contains Ambroxol 27.5mg.

[0017] Get ambroxol hydrochloride 3g, average filling in 100 No. 4 capsule shells, each capsule contains ambroxol hydrochloride 30mg.

Embodiment 2

[0018] Embodiment 2 Ambroxol Capsules and Ambroxol Hydrochloride Capsules Dog Pharmacokinetic Test

[0019] Test animals: Beagle dogs.

[0020] Test drug: ambroxol capsules and ambroxol hydrochloride capsules prepared according to embodiment 1.

[0021] Experimental method: Using self-controlled cross-over experimental design, the pharmacokinetic behavior of ambroxol in plasma at different times after oral administration of ambroxol capsules (T) and ambroxol hydrochloride capsules (R) was studied in 6 beagle dogs. , calculate the main pharmacokinetic parameters of ambroxol, and investigate whether there is a significant difference in the pharmacokinetic behavior of ambroxol capsules and ambroxol hydrochloride capsules in beagle dogs.

[0022] Test results: Ambroxol capsules and ambroxol hydrochloride capsules in Beagle dogs after oral administration of t max 1.54±0.56h and 0.67±0.48h respectively, C max They were 383.94±84.64ng / ml and 522.83±260.90ng / ml respectively, and th...

Embodiment 3

[0023] Example 3 Preparation of Ambroxol Granules

[0024] Prescription Ambroxol 27.5mg

[0025] Sucrose 962.5mg

[0026] Carmellose Sodium 10mg

[0027]Litchi essence appropriate amount

[0028]

[0029] Makes 1 bag

[0030] Preparation process: 1. All raw materials and auxiliary materials are pulverized and passed through an 80-mesh sieve for later use.

[0031] 2. Take the prescribed amount of ambroxol and carmellose sodium and mix well. Then add the prescribed amount of sucrose into it according to the method of equal addition, mix thoroughly and evenly for later use.

[0032] 3. Take a small amount of essence and add it to water (1:3) as a binder to make soft materials.

[0033] 4. Granulate with a 20-mesh sieve and dry at 60°C.

[0034] 5. Sorting with 18 mesh sieve.

[0035] 6. Separate packaging and full inspection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicinal composition of ambroxol in a non-salt form. Particularly, the invention especially relates to a composition comprising ambroxol in a base form and other oral substances with or without physiological activity or a drug container. The inventor surprisingly finds that when ambroxol is prepared into an oral preparation in a non-salt form, and especially a preparation such as a suspension, a dry suspension, a granule and the like needing to be diluted and prepared with water before drinking, the mouthfeel is significantly improved when compared with that of an ambroxol hydrochloride solution, and the ambroxol preparation has significantly slower absorption in vivo than an ambroxol hydrochloride preparation; and the realization of a slow-release effect which requires great effort on preparation process can be easily achieved. It is well known that the slow release of a drug can reduce drug side effects and increase security with the guarantee of curative effects.

Description

technical field [0001] The present invention relates to pharmaceutically acceptable compositions containing ambroxol in non-salt form. Specifically, the present invention especially relates to the composition of ambroxol in the form of a salt base and other oral substances or medicine containers with or without physiological activity. Background technique [0002] Ambroxol, English name Ambroxol, chemical name: trans-4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol. [0003] Ambroxol is a well-known expectorant, which is mainly used for those who have thick sputum and are difficult to cough up. Although ambroxol has injections, sterile powder (freeze-dried form), tablets, capsules, sustained-release preparations, oral solutions, granules, etc. in pharmaceutical dosage forms, they all use ambroxol salts, especially Hydrochloride is used as an active ingredient, and it is made by adding other corresponding auxiliary materials. [0004] Ambroxol hydrochloride oral solution i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/137A61P11/10A61K31/7048A61K31/545A61K31/65
Inventor 王鹏
Owner 沈阳华泰药物研究有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products